This inventor holds 1 USPTO granted patent. Top assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Nanjing Shunxin Pharmaceuticals Co., Ltd. of Chiatai Tianqing Pharmaceutical Group. Active years: 2026.
Company Filing History:
1 out of 11 
1 out of 1 Years Active: 2026
Title: Chao Shu: Innovator in Pharmaceutical Composition for Lung Cancer Treatment
Introduction
Chao Shu is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of small cell lung cancer. His innovative work has led to the development of a unique pharmaceutical composition that aims to improve patient outcomes.
Latest Patents
Chao Shu holds a patent for a "Combined Pharmaceutical Composition for Treating Small Cell Lung Cancer." This patent represents a crucial advancement in cancer treatment, showcasing his dedication to addressing critical health challenges.
Career Highlights
Throughout his career, Chao Shu has worked with prominent companies in the pharmaceutical industry. He has been associated with Nanjing Shunxin Pharmaceuticals Co., Ltd., which is part of the Chiatai Tianqing Pharmaceutical Group. Additionally, he has contributed to the Chia Tai Tianqing Pharmaceutical Group Co., Ltd., further solidifying his expertise in pharmaceutical innovations.
Collaborations
Chao Shu has collaborated with talented individuals in his field, including Ding Yu and Wenwen Liu. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.
Conclusion
Chao Shu's contributions to the pharmaceutical industry, particularly in the treatment of small cell lung cancer, highlight his role as an influential inventor. His work continues to inspire advancements in medical science and patient care.